New digital technologies such as smartphone apps and localization data have been used to model and monitor the COVID-19 pandemic. But along with hopes that these tools will help curb the pandemic, their use by both authoritarian and democratic governments can invoke images of dystopian surveillance. These tensions and more will be discussed Wednesday at […] Continue reading ->
A standardized set of more than 80 compounds with known or predicted activity against SARS-CoV-2, the virus that causes COVID-19, has been compiled by the Medicines for Malaria Venture in an effort to catalyze the discovery of drugs for the disease. The announcement comes amidst rapid shifts in the research around potential COVID-19 treatments. Just […] Continue reading ->
While children seem to largely escape the worst COVID-19 infections, lockdowns to curb the pandemic have increased exposure to a different threat to children’s health – abuse and violence. In Eastern Uganda, where so far no child has been infected with COVID-19, lockdowns have led to an uptick in reports of child abuse, exploitation, and […] Continue reading ->
A rising star in the COVID-19 treatment arena, dexamethasone – a powerful corticosteroid – has stirred excitement among World Health Organization experts and researchers around the world, following the publication of promising early results from the United Kingdom’s Recovery trial.  In COVID-19 patients only receiving supplemental oxygen, the trial found that dexamethasone reduced mortality by […] Continue reading ->
About 1.7 billion people, or 22% of the world’s population, has at least one underlying health condition that puts them at increased risk of becoming seriously ill with COVID-19, according to a new modelling study published in Lancet Global Health.   Based on the new assessment, about 4% of the world’s population, in total, is at […] Continue reading ->
A major clinical trial ongoing in the United Kingdom has fingered dexamethasone, a common anti-inflammatory drug used to treat arthritis and asthma, as the “first” treatment to actually reduce mortality among COVID-19 patients – by as much as one-third.  The preliminary findings were announced by the trial’s principal investigators, Martin Landray and Peter Horby, both […] Continue reading ->